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Association of Extensive Polymorphisms in the
SLAM/CD2 Gene Cluster with Murine Lupus
nally associated with “Sle1” (Morel et al., 2001). Sle1b
is the most potent member of this cluster, mediating
gender-biased and highly penetrant ANA production in
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and Edward K. Wakeland1,* ating mutations lpr or yaa, illustrating the importance of
this locus to lupus pathogenesis (Croker et al., 2003).1Center for Immunology
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meras indicate that genes in the Sle1 cluster are celland Development
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Gainesville, Florida 32611 the Sle1 cluster are expressed in lymphocytic lineages,
although we have not repeated this experiment with
bone marrow that varies at individual Sle1 cluster loci.
Here, we describe the genomic characterization ofSummary
the Sle1b locus, which identifies a highly polymorphic
seven-member cluster of SLAM/CD2 family genes in theSusceptibility to autoimmunity in B6.Sle1bmice is as-
middle of the Sle1b critical interval. Analyses of thissociated with extensive polymorphisms between two
family reveal extensive sequence and expression-leveldivergent haplotypes of the SLAM/CD2 family of
differences between B6 and B6.Sle1b and associate agenes. The B6.Sle1b-derived SLAM/CD2 family haplo-
subset of SLAM/CD2 family members with autoimmu-type is found in many other laboratory mouse strains
nity. Given the well-established role of this family in thebut only causes autoimmunity in the context of the
modulation of cellular activation and signaling in theC57Bl/6 (B6) genome. Phenotypic analyses have re-
immune system, they are ideal candidates for mediatingvealed variations in the structure and expression of
the Sle1b phenotype (for reviews, see Veillette and La-several members of the SLAM/CD2 family in T and B
tour, 2003; Veillette, 2004; Sidorenko and Clark, 2003;lymphocytes from B6.Sle1bmice. T lymphocytes from
Tangye et al., 2000; Engel et al., 2003).B6.Sle1b mice have modified signaling responses to
stimulation at 4–6 weeks of age. While autoimmunity
may be mediated by a combination of genes in the Results
SLAM/CD2 family cluster, the strongest candidate is
Ly108, a specific isoform of which is constitutively Mapping and Sequencing the Sle1b
Congenic Intervalupregulated in B6.Sle1b lymphocytes.
The location of Sle1b was determined by analyzing a
series of congenic strains carrying truncated intervals,Introduction
and the final two congenic truncations defining Sle1b
are presented in Figure 1A. Fine mapping of the con-Genetic predisposition is a central element in suscepti-
genic ends of these two strains found that the telomericbility to many common autoimmune diseases, including
end of B6.FcR overlaps with the centromeric end ofsystemic lupus erythematosus (SLE) (Wandstrat and
B6.Sle1b. As shown in Figure 1B, B6.Sle1b spontane-Wakeland, 2001; Wakeland et al., 2001; Vyse and Todd,
ously produces ANA in a highly penetrant, gender-biased1996). We have used congenic dissection to character-
manner, while B6.FcR does not. This localizes Sle1b toize the susceptibility genes in the lupus-prone NZM2410
the genomic segment defined by the telomeric end ofmouse (Morel et al., 1994, 2000; Mohan et al., 1998).
B6.FcR and the telomeric end of B6.Sle1b (Figure 1A).These analyses identified Sle1, on murine chromosome
A BAC contig spanning the Sle1b interval was con-1, as causal for a loss in immune tolerance that leads
structed by using a C57Bl/6J-derived BAC library pro-to antinuclear autoantibody (ANA) production, on the B6
duced by de Jong and coworkers (Osoegawa et al.,background. Interestingly,Sle1 is syntenic with genomic
2000) and the CJ7/129Sv-derived CalTech library (Shi-intervals that are associated with susceptibility to SLE
zuya et al., 1992) (Supplemental Figure S1). Polymorphicin human linkage studies (Tsao et al., 1997; Moser et
markers derived from this contig positioned the telo-al., 1998).
meric end of B6.FcR to an 10 kb interval betweenFine mapping of Sle1 revealed a cluster of four loci
ApoA2 and B4galt3, and that of B6.Sle1b to an 15 kb(designated Sle1a–Sle1d) within the B6.Sle1 congenic
interval between Copa and Pxf (Figure 2A). This posi-interval, eachcontributing someof thephenotypes origi-
tions Sle1b within a genomic segment that is spanned
by a tiling path of seven C57Bl/6J-derived BACs from
*Correspondence: edward.wakeland@utsouthwestern.edu
the RPCI-23 library (194d6, 48o11, 171k8, 145f9, 77a8,4These authors contributed equally to this work.
438k9, and 462j8) (Supplemental Figure S1).5Present address: Maize Mapping Project, University of Missouri,
Columbia, Missouri 65211. More than 8700 high-quality sequence reads were
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genomic segment that contains 2 pseudogenes and 24
expressed genes, 19 of which are expressed in the
spleen (bolded in Figure 2A). Most notably, seven mem-
bers of the SLAM/CD2 gene family (Cd244, Cd229, Cs1,
Cd48, Cd150, Ly108, Cd84) are clustered in the center
of the Sle1b critical interval. These genes encode cell
surface molecules that mediate stimulatory and/or in-
hibitory signaling during cell-cell interactions between
several hematopoietic cell lineages and are the only
genes located within the Sle1b critical interval with obvi-
ous immunological functions (Engel et al., 2003; Sido-
renko and Clark, 2003).
Extensive Polymorphisms Distinguish the SLAM/CD2
Family Genes in B6 and B6.Sle1b
Two features of Sle1b were used to evaluate the candi-
dacy of genes within the critical interval: (1) Sle1b may
be expressed in many tissues, but is expressed in the
spleen; and (2) Sle1b must be functionally polymorphic
between B6 and B6.Sle1b. Quantitative real-time PCR
(RT-PCR) and Northern blot analysis determined that
19 genes within the critical interval are expressed in
splenocytes, and 16 of these are expressed in B and
T cells (Figure 2D). Functional polymorphisms in these
19 candidate genes were identified via structural and
regulatory comparisons of the B6 and B6.Sle1b alleles.
Structural polymorphisms were found by comparing al-
lelic sequences from B6 and B6.Sle1b for each exon,
together with relevant surrounding intronic material and
5 and 3UTRs. Transcriptional variations in these genes
were assessed by real-time quantitative RT-PCR analy-
Figure 1. Congenic Derivation of the Minimal Sle1b Interval sis in B and T lymphocytes from age- and gender-
(A) Genetic map and truncated congenics used to define Sle1b. Fine matched B6 and B6.Sle1b mice.
mapping of Sle1b was previously described (Morel et al., 2001). These analyses revealed extensive polymorphisms
A high-resolution map of telomeric chr 1 was produced with 46
between B6 and B6.Sle1b, predominantly occurring inmicrosatellite markers (Dietrich et al., 1996) polymorphic between
genes of the SLAM/CD2 family. As summarized in FigureB6 and NZM2410. Their positions were mapped on 493 (NZM2410
B6) meioses from two crosses (Morel et al., 1994, 2001), and they 2 and Table 1, five members of the SLAM/CD2 family
were used to genotype (B6.Sle1B6) F1 B6 progeny for recombi- cluster (Cd244,Cd229,Cs1,Cd48,Cd84) have transcrip-
nants within the Sle1 congenic interval. tional and structural polymorphisms with potential func-
(B) Progeny carrying selected congenic intervals showing a positive tional consequences. Cd229, Cd84, and Cd48 contain
phenotype were intercrossed to homozygosity and expanded. A
a total of seven nonsynonymous mutations in exonstotal of 16 mice/group were aged to 12 months. Sera were screened
encoding their ligand binding domains. The potentialfor antichromatin IgG autoantibodies every other month from 6 to
12 months by ELISA as previously described (Mohan et al., 1998). functional consequence of these sequence changes on
For interplate comparisons, a serial dilution of an NZM2410 serum the structure of the binding domains of these alleles
was included on each plate to construct a standard curve. The OD were assessed by aligning their sequences with rat and
value for a 1:100 dilution was assigned a value of 100 units. A sample human CD2, whose molecular structures have been
was deemed positive when it scored greater than 25 units, the mean
solved (Figures 2B and 2C; Cn3D alignment) (Somozavalue  2 SD of 50 12-month-old B6 controls.
et al., 1993; Jining et al., 2004). The polymorphism lo-
cated in Cd84 was found to be just proximal to the
location of the A  sheet of the N-terminal V-Ig-likeassembled for the analysis of theBAC inserts in this tiling
path, which, when combined with sequence available in domain (Figure 2B). Of the four polymorphisms in the
extracellular region of Cd229 (Figure 2C), two (aa 58 andpublic databases (www.genome.ou.edu), provided be-
tween 9- and 19-fold coverage for the entire interval and 70) occur in the C and C  sheet of the N-terminal
V-Ig-like domain, respectively. Polymorphisms at aminoproduced a C57Bl/6J consensus sequence composed
of 10 ordered contigs (GenBank accession number acid position 109 are in the F  sheet of the N-terminal
C-Ig-like domain, while position 118 is just proximal toAY819658). This sequencewas analyzed by using a vari-
ety of gene-finding software, including PANORAMA the G  sheet. Two recent studies implicate segments
of the binding site in ligand interactions. As shown in(Pertsemlidis et al., 2000) (http://atlas.swmed.edu), Gene-
scanII (Burge and Karlin, 1997) (http://genes.mit.edu/ Figure 2C, two of the polymorphisms located in the
Cd229 molecule (aa 58 and 118) align with interfaceGENSCAN.html), andHMMgene (Krogh, 1997) (http://www.
cbs.dtu.dk/services/HMMgene). As shown in Figure 2A, contact residues in the hCD2-hCD58 structure (Jining
et al., 2004). Furthermore, a recent analysis of Cd229the Sle1b region is located between 171.3 Mb and 172.2
Mb along chromosome 1. This is a gene-dense 900 kb mutants implicated residues located in the C  sheet of
SLAM/CD2 Genetic Diversity and Autoimmunity
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Figure 2. Candidate Gene Analysis of the Sle1b Congenic Interval A
(A) Molecular map of Sle1b. The peak linkage marker D1Mit113 resides within the CD150 gene. The gray bar denotes the area in the Sle1b
region by congenic breakpoint mapping. Hatched bars denote the area outside the Sle1b interval. Arrows denote the transcriptional direction
of genes. Lines without arrows denote pseudogenes. Spleen-expressed genes are indicated in bold.
(B and C) Sequence alignment of rat and human CD2 with B6 and NZW versions of (B) Cd84 and (C) Ly9 extracellular regions.  strand
positions were determined from rat Cd2 structure and marked by an overline. Boxed residues denote polymorphisms between the murine
strains. #, Interface contact residues in the hCD2-hCD58 structure; *, residues in the interface.
(D) Gene expression in B and CD4 T cells of candidate genes in 6- to 8-week-old female B6 and B6.Sle1b mice (n  5–7) by real-time PCR.
Data are expressed as relative fold differences compared to B6. The gray hatched box represents a 2-fold difference, which is used as the
minimal cutoff for identifying genes that are differentially expressed.
(E) Splenic suspensions were stained with anti-B220, -CD4, -CD8, and -CD48. There were significant differences (p  0.05) in the Median
Fluorescent Intensities (MFIs) of CD48 on B220 B cells, CD4 T cells, and CD8 T cells.
the N-terminal V-Ig-like domain (such as residue 58) Six non-SLAM/CD2 family genes in the Sle1b interval
have one or more nonsynonymous mutations (Table 1).in the homophilic binding of this molecule (Romero et
al., 2004). Usp23, Nit1, Refbp2, Ncstn, Copa, and Pxf are ubiqui-
tously expressed genes that have functions inmetabolicThe SLAM/CD2 alleles of B6.Sle1b also differed from
those of B6 in gene copy number. Genomic analysis of and cellular processes, with no obvious immunological
roles (Sacksteder et al., 2000; Smith and Southan, 2000;Cd244, a SLAM/CD2 family gene expressed in NK cells
and CD8 T cells (but not B cells), determined that this Pekarsky et al., 1998; Yu et al., 2000; Quek and Chow,
1997). Nicastrin (Ncstn) is a component of the -secre-gene is expanded from a single locus in B6 to a 4-locus
cluster (Supplemental Figure S2). Transcripts from three tase complex, which functions as a protease to trans-
duce signals of cell surface receptors. Although thisof these Cd244 genes were detected in splenic cDNA
preparations, and all three encode binding domains that complex has been shown to process type I integral
membrane proteins, including Cd44 and the Notch li-are highly divergent from that of the single Cd244mole-
cule expressed in B6. Sequence analysis of B6.Sle1b gands Delta and Jagged, the functional implications re-
main unclear (Kimberly and Wolfe, 2003). Furthermore,splenic cDNAs suggests that one of these three Cd244
genes is expressed preferentially, although transcripts the mutations in these genes are not located in highly
conserved positions (Table 1) or in motifs impactingfrom all three genes are detectable in splenocytes. The
functional consequences of these extensive variations protein phosphorylation, acetylation, and/or glycosyla-
tion (based on analysis with PROSITE [www.expasy.ch/in Cd244 structure on NK cell function remain to be de-
termined. prosite]). All of the synonymous and nonsynonymous
Immunity
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Table 1. Analysis of the Productive Sequence Polymorphisms between the B6 and B6.Sle1b Alleles
GenBank Amino Acid Changea Other Speciesb
Accession Position
Gene Function Number (Amino Acid) B6 NZW Conserved Not Conserved
Usp23 Intracellular protein BAB27431 341 C R Human Rat, Drosophila, Yeast
breakdown and cell
cycle regulation
Nit1 Cleaves nitriles and NP_036179 22 T I Human
organic amides
Refbp2 RNA and export factor NP_062357 151 T A Human, Rat, Chicken, Drosophila, Arabidopsis
binding protein 2 Xenopus
Cd229 Adhesion/costimulatory NP_032560 58 I T Human
molecules that regulate
the activation threshold
in many immune cell
lineages
70 F S Human
109 H Y Human
118 I T Human
345 K N Human
356 E K Human
571 G E Human
Cs1 See Cd229 AAH11154 248 M T Human
253 G R Human
Cd48 See Cd229 P18181 4 I R Human Rat
90 N D Rat Human
Cd84 See Cd229 NP_038517 27 V M Human
Ncstn Integral membrane AAH19998 21 S F Human
protein that interacts
with presenilin-1 and -2
678 T I Human Drosophila, C. elegans,
Arabidopsis
680 V I Human, Drosophila, Arabidopsis
C. elegans
Copa Housekeeping gene NP_034068 761 S T Human, Drosophila, C. elegans
Arabidopsis
984 N S Human Drosophila, C. elegans,
Arabidopsis
1110 N S Human, Drosophilia, Arabidopsis
C. elegans
Pxf Peroxisomal biogenesis NP_075528 55 P Sc Human, Rat, Hamster Drosophilac, C. elegans
a The amino acids that are underlined represent the conserved version.
bThe sequence was not available for every species.
cS is conserved in Drosophilia.
polymorphisms found in the SLAM/CD2 family and non- guished six of the seven genes in the SLAM/CD2 cluster.
Many of these structural mutations impact molecularSLAM/CD2 family genes are presented in Supplemental
Table S1. domains essential for the functions of these molecules.
In addition, four of these genes vary between B6 andFour members of the SLAM/CD2 family, Cd48, Ly108,
Cd84, andCs1, vary in their expression in splenic B and/ B6.Sle1b in their lymphocyte expression levels. In con-
trast, non-SLAM/CD2 family members exhibit much lessor T cells between B6 and B6.Sle1b (Figure 2D). Cd84
and Ly108 are upregulated in B cells from B6.Sle1b structural variability and have no detectable changes in
expression between B6 and B6.Sle1b.mice, while Cs1, Cd48, and Ly108 are downregulated in
B6.Sle1b T cells. This differential expression was con-
firmed in B and T cell subsets at the cell surface level Polymorphic SLAM/CD2 Family Haplotypes
and the Development of Autoimmunityfor Cd48, the only member for which a commercially
available monoclonal antibody that recognizes both the The Sle1b genomic region was characterized in a panel
of inbred laboratorystrains todeterminewhether thehighlyB6 and B6.Sle1b alleles exists (Figure 2E). These varia-
tions in expression were detected in young female mice divergent SLAM/CD2 family gene cluster in B6.Sle1b is
a unique feature of the genome of the NZM2410 strain.(12 weeks) well prior to the development of ANA or
anyother autoimmunephenotypes. In contrast, no varia- Sequence analysis of the extracellular Ig regions of the
SLAM/CD2 family revealed that, surprisingly, most oftions in expression were found among the non-SLAM/
CD2 family positional candidates (Figure 2D). these strains carry alleles throughout the Sle1b interval
that are indistinguishable from those of B6.Sle1b. TheIn summary, genomic analyses detected extensive
variations between B6 and B6.Sle1b within this region, analysis was extended to a set of SNPs in genes flanking
the SLAM/CD2 family. As shown in Figure 3A, the SNPspredominantly in the SLAM/CD2 family cluster. Exten-
sive structural and regulatory polymorphisms distin- within this genomic segment form two stable haplotypes
SLAM/CD2 Genetic Diversity and Autoimmunity
773
Figure 3. Haplotype Analysis of the Sle1b Interval
(A) The Ig domains of the SLAM/CD2 genes, and a subset of SNPs from flanking genes, were sequenced in 34 inbred laboratory strains. Two
stable, divergent haplotypes (Haplotypes 1 and 2) were observed. SNPs that distinguish between the two haplotypes are shown as solid black
lines, and the genes falling into the haplotype block are highlighted in gray. Cd244 shows gene expansion into a four-gene locus in Haplotype
2. SNPs that lie outside the haplotype region and do not follow strain-specific patterns are shown as dotted gray lines. Asterisks represent
additional SNPs found in a single strain.
(B) SNPs in the SLAM/CD2 family region define two separate haplotypes among all inbred laboratory strains. This table shows strains that
share the B6-like version (SLAM/CD2 Haplotype 1) and the B6.Sle1b-like version (SLAM/CD2 Haplotype 2). Analysis of 14 wild-derived inbred
strains identified additional strains carrying either haplotype, or some recombinants with part of Haplotype 1 and part of Haplotype 2.
(C) Penetrance of ANA production in congenics at the Sle1b locus, derived from NZM2410, 129/SvJ, and CAST/Ei. Sera from nine or more
9-month-old female mice were assayed for  total histone/dsDNA IgG ANA by ELISA. Sera were assayed at a dilution of 1:800. For interplate
comparisons, serial dilutions of a chromatin-specific hybridoma supernatant were included to construct a standard curve. Sera were considered
positive if they scored higher than the mean value  4 SD of 11- to 12-month-old B6 females.
(D) Allelic comparisons between the autoimmune-prone B6.Sle1b, B6.129c1, and B6.CASTc1 congenic mice and B6 were performed for all
the productive polymorphisms previously found in the Sle1b candidate genes. B6 alleles are shown as white arrows. NZM2410 and 129/SvJ
share the same alleles, shown as gray arrows. The exception is Copa, for which 129/SvJ differs from NZM2410 by a single productive SNP.
CAST/Ei alleles not shared with B6 or B6.Sle1b are shown as hatched arrows.
across all the inbred laboratory strains assayed. The SLAM/CD2 haplotype 2 from the nonautoimmune 129/
SvJ strain onto the C57Bl/6/J background (Wakeland etmost conserved segment of the haplotype is centered
over theSLAM/CD2 family, and itdeterioratesdistal toDedd al., 1997). As shown in Figure 3C, although age-matched
129/SvJmice areANAnegative, B6.129c1micehomozy-on the centromeric side and proximal to Pea15 on the
telomeric side. A list of all of the SNPs analyzed in the gous for the 129-derived SLAM/CD2 haplotype 2 on the
B6 background have highly penetrant ANA productionregion and the subset that define the SLAM/CD2 family
haplotype, alongwith the inbred laboratory strains used, and are phenotypically indistinguishable from B6.Sle1b.
Interestingly, Bygrave et al. recently reported a similarcan be found in Supplemental Table S2. The autoim-
mune-associated haplotype of B6.Sle1b, termed SLAM/ ANA phenotype in a B6.129c1 congenic strain encom-
passing the Sle1b interval (Bygrave et al., 2004). TheseCD2 haplotype 2, is the most common version in labora-
tory strains, being detected in every autoimmune-prone findings suggest that the SLAM/CD2 haplotype 2 of 129/
SvJ and B6.Sle1b are equivalent in their capacity tostrain analyzed as well as many nonautoimmune strains
such as 129/SvJ (Figure 3B). mediate autoimmunity and that one or more additional
allelic variations in the B6 genome interact with thisThe prevalence of SLAM/CD2 haplotype 2 among
nonautoimmune strains indicated that either this haplo- haplotype to cause autoimmunity. This result illustrates
the importance of epistatic interactions with the B6 ge-type interacts with an additional gene(s) from the C57BL/6
genome to breach tolerance, or that an unidentified mu- nome in the autoimmune phenotypes associated with
Sle1 (Morel et al., 1999; Wakeland et al., 2001).tation unique to the SLAM/CD2 haplotype 2 in B6.Sle1b
is responsible for the development of autoimmunity. To Although the Sle1b interval occurs as two stable hap-
lotypes among the standard inbred strains, a detailedaddress this issue, we utilizedmarker-assisted selection
to introgress a minimal congenic interval containing the analysis of wild mice revealed extensive additional di-
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versity and recombination throughout the entire region and Ruley, 2000). Hybridizations with isoform-specific
probes suggest that it is related to Ly108-1, and not(N.L., K. Belobrajdic, A.Y.C., A.E.W., F. Bonhomme, S.
Edwards, and E.K.W., unpublished data). Fourteen fully Ly108-2 (data not shown). Real-time quantitative RT-
PCR of the Ly108-1 and Ly108-2 isoforms in B and CD4inbred strains, derived from wild mouse stocks of differ-
ent Mus subspecies, were also analyzed for the SLAM/ T cells from B6 and B6.Sle1b confirms that these iso-
forms are divergently expressed between B6 andCD2 family haplotype. Several of these strains carry
recombinant versions of this region that share some B6.Sle1b (Figure 4C, seven mice/group). This variation
in isoform expression results in a 	5-fold increase inalleles with B6, some with B6.Sle1b, and some unique
alleles (Figure 3B, Supplemental Figure S3). These the ratio of Ly108-1 to Ly108-2 in B6.Sle1bB and T cells.
Analyses of RNA from B6.Castc1, NZW, and a panel ofstrains may prove to be invaluable in further mapping
the gene(s) mediating autoimmunity in this region. Most inbred strains confirm that preferential expression of the
Ly108-1 isoform is characteristic of SLAM/CD2 haplo-notably, we find that the CAST/Ei strain, which is derived
from wild Mus m. castaneus stocks, carries one such type 2 (Figure 4B and Supplemental Figure S4). In addi-
tion to differential isoform expression of Ly108, an addi-recombinant version of the region. As shown in Figure
3C, B6.Castc1 congenic mice, which carry a CAST/Ei- tional splice variation in Cd229 was also observed in
B6.Sle1b and NZW splenocytes, although this isoformderived Sle1b interval introgressed onto the C57Bl/6
background (Wakeland et al., 1997), also develop highly was absent from both B6 and B6.Castc1 (Figure 4D).
penetrant ANA and are phenotypically indistinguishable
from B6.Sle1b mice. While the congenic interval in Autoimmune-Associated SLAM/CD2 Family Alleles
B6.Castc1 is similar in size to that of B6.Sle1 and conse- Modify CD4 T Cell Activation
quently may contain other genes influencing autoimmu- The role of SLAM/CD2 family genes in modulating sig-
nity (although CAST/Ei mice are not reported to be auto- naling during cellular interactions suggests that these
immune-prone), a comparison of the structure of the polymorphisms might mediate autoimmunity via modu-
Sle1b region in B6.Castc1 with B6.Sle1b and B6.129c1 lating cellular responses to activation. Consequently,
provides some useful insights. B6.Castc1 carries alleles we assessed the properties of T, B, andmonocyte popu-
of Nit1, Pxf, Ncstn, and Copa that are similar or identical lations in young B6.Sle1b mice extensively, with the
to B6 (Figure 3D, Supplemental Table S3), arguing intention of identifying intrinsic functional changes cor-
against a role for these alleles in autoimmunity caused related with a predisposition to autoimmunity. At 4–6
by Sle1b. B6.Castc1 also excludes the amplification of weeks of age, B6.Sle1b mice do not have detectable
Cd244 as a candidate genetic polymorphism for Sle1b, autoimmunity, and their lymphocytic cellular profiles are
in that B6.Castc1 has a single Cd244 gene closely re- indistinguishable from normal B6 (Mohan et al., 1998)
lated to that of B6. Two SLAM/CD2 family genes, Cd229 (Supplemental Table S4); although, as described above,
and Cs1, are also unique alleles, while the remaining they do vary from B6 in the transcriptional expression
SLAM/CD2 family alleles are shared by B6.Castc1 and of specific SLAM/CD2 family genes. As shown in Figure
B6.Sle1b. These results indicate that B6.Castc1 carries 5, comparisons of B6 versus B6.Sle1bCD4 T cells reveal
a SLAM/CD2 family gene cluster that is most identical a significant change in both the peak value and persis-
to B6.Sle1b in the telomeric portion of the haplotype. tence of Ca2 flux levels produced by stimulation
through the TCR complex with a cocktail of monoclonal
Abs. These results are consistent with an intrinsic in-Genetic Variations in Expression of SLAM/CD2 Family
crease in the activation of B6.Sle1b-derived CD4 T cellsMembers between Nonautoimmune B6
by TCR stimulation. Similar results were obtained withand Autoimmune-Prone Congenic Strains
both B6.Castc1-derived and B6.129c1-derived CD4Previous studies have reported several splice-gener-
T cells, indicating that this activation phenotype corre-ated isoforms of members of the SLAM/CD2 gene family
lates with both predisposition to autoimmunity and the(Wang et al., 2001; Peck and Ruley, 2000; Palou et al.,
presence of the autoimmune-prone SLAM/CD2 family2000; Stepp et al., 1999; de la Fuente et al., 1999). Poly-
haplotype. A similar analysis of B cells from these strainsmorphisms in splice isoform expression are likely to
failed to reveal any measurable differences in Ca2 fluxhave functional consequences and have been impli-
levels in young mice (data not shown).cated as candidates for other autoimmune susceptibility
loci (Blomhoff et al., 2004; Ueda et al., 2003; Muschen
et al., 1999). Comparisons of SLAM/CD2 family isoform Discussion
levels in B6 and B6.Sle1b revealed significant differ-
ences in isoform usage for both Cd229 and Ly108. As Genomic analysis of the critical interval for Sle1b has
identified members of the SLAM/CD2 family gene clus-illustrated in Figure 4A, Ly108 produces two splice iso-
forms (here termed Ly108-1 and Ly108-2) that differ by ter as the strongest candidate genes for the potent auto-
immune phenotypes associated with Sle1b. The geneexpressing alternative exons that encode divergent cy-
toplasmic signaling domains (Peck and Ruley, 2000). cluster is highly polymorphic, and autoimmunity is elic-
ited in three independently derived congenic strains car-Interestingly, Ly108-1 contains two TxYxxV/I/A ITSM
signalingmotifs, while Ly108-2 contains three. As shown rying identical alleles for the telomeric portion of the
SLAM/CD2 gene cluster. This suggests that the SLAM/by Northern analysis in Figure 4B, B6 splenocytes prefer-
entially express isoform Ly108-2, while B6.Sle1b spleno- CD2 haplotype 2-derived alleles of Cd48, Cd150, Cd84,
and Ly108 are the strongest susceptibility gene candi-cytespreferentially express isoformLy108-1. Anadditional
high-molecularweightbandwasalsoobserved inB6.Sle1b, dates. Although Ly108 exhibits an intriguing preferential
isoform expression, making it the strongest single genewhich is thought to be a partially spliced variant (Peck
SLAM/CD2 Genetic Diversity and Autoimmunity
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Figure 4. Differential Isoform Expression Associated with the Two SLAM/CD2 Haplotypes
(A) Ly108 has two alternative splice forms that differ in the 3 end (Peck and Ruley, 2000). Ly108-1 is composed of exons 1–8, whereas Ly108-2
shares exons 1–7 and splices to exon 9.
(B) Northern blotting of splenic total RNA reveals differences in isoform expression between the two SLAM/CD2 haplotypes. Ly108-1 is
upregulated, while Ly108-2 is downregulated in B6.Sle1b, NZW, and B6.Castc1, compared to B6.
(C) Isoform expression of Ly108 in B6 and B6.Sle1b (n  7) was confirmed by real-time RT-PCR in B and CD4 T cells by using isoform-
specific primers.
(D) Cd229 exhibits a difference in expression between B6 and B6.Sle1b via Northern blotting. B6.Sle1b and NZW show an additional possible
isoform, while the autoimmune B6.Castc1 resembles B6.
candidate, it is equally feasible that more than one of modulate a variety of immune functions, depending on
the availability of downstream molecules in their signal-these alleles participates in susceptibility to autoimmu-
nity. In such a scenario, autoimmunity would be caused ing pathways (for reviews, see Engel et al., 2003; Veillette
and Latour, 2003; Veillette, 2004). Due to the complexi-by the combined impact of two or more divergent alleles
in the SLAM/CD2 family, possibly by influencing the ties of these signaling processes, the functional con-
sequences of stimulation through these molecules arefunctional properties of multiple immune cell lineages.
The association of autoimmunity with a polymorphic dependent upon a variety of factors, including their ex-
pression levels, the functional avidity of their interac-haplotype, rather than a single allele, is reminiscent of
the long-established association of polymorphisms in tions, and the milieu of downstream signal transduction
molecules expressed within the interacting cells. A vari-themajor histocompatibility complexwith autoimmunity
(Vyse and Todd, 1996), as well as the recently reported ety of studies have demonstrated that their activation
can modulate numerous immune functions, includingassociation of Crohn’s disease with polymorphisms in
the human cytokine gene cluster (Rioux et al., 2001). T cell activation, cytokine secretion, and cytotoxicity
(Howie et al., 2002; Shlapatska et al., 2001).SLAM/CD2 family molecules have been shown to
transmit both stimulatory and inhibitory signals during Our analysis of Sle1b has revealed that the SLAM/
CD2 gene cluster is extremely diversified in wild micecell-cell interactions between T cell, B cell, monocyte,
and NK cell lineages (Tangye et al., 2000; Sidorenko and and that two haplotypes are prevalent among standard
laboratory mouse strains. SLAM/CD2 haplotypes 1 andClark, 2003; Engel et al., 2003). Each SLAM/CD2 family
molecule is expressed in a specific set of immune cell 2 encode molecules that differ by multiple structural
polymorphisms in regions critical to ligand binding, inlineages, and their expression is upregulated bya variety
of stimuli, including activation by antigen receptor sys- expression levels on B and T lymphocytes, and in their
preferential expressionof specific isoforms. Suchchangestems, Toll receptors, and cytokines. Their costimulatory
functions are activated via their adhesion during cog- would be predicted to modulate their signaling proper-
ties during cellular interactions in the immune systemnate antigen recognition between effector cells and
APCs or targets. Phosphorylation of the ITSM motifs in and significantly impact immune activation. The prefer-
ential expression of a specific isoform of Ly108 in SLAM/their cytoplasmic domains activates their capacity to
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Figure 5. B6.Sle1b T Cells Show a Difference in Calcium Flux Compared to B6
(A) T cell-enriched splenocytes from B6, B6.Sle1b, B6.129c1, and B6.Castc1 were labeled with Fluo-3 and stimulated with anti-TCR, anti-
CD4, and anti-CD8. The representative raw dot plots depict Fluo-3 intensity as a function of time, and the arrows indicate when each reagent
was added.
(B) Calcium concentrations were plotted as a function of time. B6.Sle1b, B6.129c1, and B6.Castc1 (four or more mice/strain) exhibit an
exaggerated response after the initial calcium spike. A paired Student’s t test reveals a p value of 0.014 between B6 and B6.Sle1b (n  4).
CD2 haplotype 2 is especially intriguing in this regard, et al., 1998). Interestingly, EBV infection has been impli-
cated as an environmental trigger for SLE, raising thesince splice variants of Cd244 have been shown to dif-
ferentiallymediate themolecule’s inhibitory and stimula- possibility that SLAM/CD2 cluster-mediated variations
in the immune response to EBV infection may potentiatetory functions (Schatzle et al., 1999). Thus, the variation
in Ly108 splice variants that distinguish SLAM/CD2 hap- the development of autoimmunity (James et al., 2001;
Moon et al., 2004; Kang et al., 2004). The link betweenlotypes 1 and 2 may reflect a significant change in the
function of this molecule. Similar splice variations have autoimmunity and the SLAM/CD2 gene cluster is
strengthened by evidence that mice deficient in thebeen implicated in allelic variations associated with
other autoimmune susceptibility genes (Blomhoff et al., adaptor molecule SH2D1A or SLAM-associated protein
(SAP), which directly binds to various members of this2004; Ueda et al., 2003; Muschen et al., 1999).
The extensive diversity detected in immunoregulatory family of receptors, are protected from the experimental
pristane-induced model of lupus (Hron et al., 2004).gene clusters such as the SLAM/CD2 gene cluster may
be a consequence of pathogen-driven selection, which Given our association of variations in the SLAM/CD2
cluster with lupus susceptibility in mice, further workis anticipated to favor the maintenance of polymor-
phisms that functionally diversify immune responses on the relationship of polymorphisms in the SLAM/CD2
cluster with susceptibility to SLE in humans is clearlyagainstmicrobial pathogens (Slev and Potts, 2002). Sev-
eral studies associate polymorphisms in the SLAM/CD2 warranted.
Our analyses demonstrate that SLAM/CD2 haplotypefamily with resistance to viral diseases, including a
prominent role in the regulation of EBV infections (re- 2 alleles causeautoimmunitywhen they are expressed in
the B6 strain, but not in several other laboratory strains,viewed in Sidorenko and Clark, 2003). This connection
is intriguing with respect to the candidacy of SLAM/CD2 including 129/SvJ and NZW. As illustrated in Figure 6,
these results suggest that the combination of the signal-family polymorphisms as susceptibility alleles in human
SLE. The human SLAM/CD2 family cluster is located in ing properties of SLAM/CD2 haplotype 2 alleles with the
downstream signal transduction pathways expressed in1q23, a region in the human genome that has been
associated with SLE susceptibility in multiple human the B6 genome results in spontaneous autoimmunity.
However, a variety of studies have demonstrated thatlinkage studies (Tsao et al., 1997; Shai et al., 1999;Moser
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Figure 6. A Model Depicting How SLAM/CD2 Haplotype 2 Mediates Autoimmunity in the
Context of the B6 Genome
We propose that the autoimmunity mediated by Sle1b is a consequence of the SLAM/CD2 family alleles, in combination with genetic variations
in downstream signaling molecules. In the context of the 129/SvJ or BALB/c genomes, SLAM/CD2 haplotype 2 does not cause elevated ANA
production. On the other hand, the imbalance between the SLAM/CD2 haplotype 2 alleles and signaling molecules found in the B6 genome
(shown in the center panel) results in spontaneous autoimmunity, as seen in the B6.Sle1b, B6.129c1, and B6.Castc1 congenic lines.
the functional consequences of the signals transmitted tance of contributions from the B6 genome to the
autoimmune phenotypes of Sle1 was previously re-bySLAM/CD2molecules aredependent upon their inter-
actions with several signal transduction pathways (re- vealed by our analysis of interactions between NZW and
B6.Sle1; in these analyses, we identified four loci inviewed in (Veillette and Latour, 2003; Veillette, 2004;
Engel et al., 2003), and genetic variations affecting the NZW, which we designated Sles1–Sles4 (for SLE sup-
pressor [Morel et al., 1999]), that suppress the autoim-functions of these pathways would be predicted to influ-
ence the consequences of SLAM/CD2 family signaling munity elicited by B6.Sle1. It is tempting to speculate
that some of these suppressive modifiers may impacton the immune system. Thus, the signaling characteris-
tics of SLAM/CD2 haplotype 2 are balanced by the the signal transduction pathways that interface with
SLAM/CD2 family molecules.downstream signal transduction properties expressed
in the immune systems of inbred strains such as 129/
Experimental ProceduresSvJ, C3H, or BALB/c, and as a result, these mice are
nonautoimmune. However, the combination of SLAM/
MiceCD2 haplotype 2 and the signal transduction milieu ex-
Mice were kept under specific pathogen-free (SPF) conditions at
pressed in B6mice results in a poorly regulated immune theUniversity of Texas SouthwesternMedical Center. The introgres-
system that is prone to autoimmunity. Finally, the ob- sion of SLAM/CD2 from 129/SvJ onto C57BL/6 was performed by
served autoimmunity of B6.129c1 mice suggests cau- using marker-assisted selection protocols (Wakeland et al., 1997)
and required five backcross generations to C57BL/6. The B6.129c1tion in the interpretation of autoimmune phenotypes ex-
congenic carries a 129-derived congenic interval from D1MIT148 topressed in mice with gene ablations that have B6 
D1MIT115 (roughly 4 Mb) and includes Sle1b, but excludes Sle1a,129 hybrid genomes, as we and others have suggested
Sle1d, and Sle1c. The B6.Castc1 congenic strain has a congenic
previously (Wakeland et al., 2001; Bygrave et al., 2004) interval similar in size to that of B6.Sle1.
The observed changes in Ca2 flux properties of CD4
T cells as a consequence of moving SLAM/CD2 haplo- BAC DNA Extraction and Insert Sequencing
type 2 onto B6 are consistent with modification in the BAC DNA was prepared by following the Wellcome Trust Centre for
Human Genetics and Institute of Molecular Medicine protocolactivation status of the immune system.
(http://www.molbiol.ox.ac.uk/jmejia/more_protocols.html). For se-These results provide a clear example of the manner
quencing libraries, BAC DNA was sheared in a nebulizer (Glas-Col,in which epistatic interactions between polymorphic ge-
Inc.) at 150 psi nitrogen for 2.5 min. Fragment ends were mendednetic systems can lead to autoimmune susceptibility. In
by incubation with 0.2 mM dNTPs, 40 U T4 DNA polymerase for 15
this model, SLAM/CD2 haplotype 2 alleles in combina- min at RT and the addition of 25 U Klenow for 1 hr at RT. DNA was
tion with one or more polymorphic genes in the B6 ge- purified by phenol-chloroform extraction and ethanol precipitation
and was run on a 1% agarose gel. 1–3 kb fragments were extractednome lead to an imbalanced immune system. The impor-
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by using the GenecleanII kit (Qbiogene) and were ligated into the (MEL-14), CD44 (1M7), CD8 (53-6.7), CD138 (281-2), and Streptavi-
din-APC. Isotype controls for all antibody combinations were in-pUC18 vector by using the Rapid Ligation Kit (Roche Boehringer
Mannheim). DH5 TM-competent cells (Invitrogen) were trans- cluded. Stained cells were analyzed by using a FACsCalibur (BD
Biosciences). A total of 40,000 live events within the lymphocyteformed and plated onto LB plates with 100 
g/ml ampicillin, 50 
g/ml
X-gal, and 1 mM IPTG. Plasmid DNA was extracted by using an Auto- gate were acquired per sample. Data were analyzed with FlowJo
(Treestar).gen 740 (AutoGen) and was sequenced by using M13 primers on the
Beckman CEQ 2000XL (Beckman Coulter). Sequence was assembled
with Phred, Phrap, and Consed (see http://www.phrap.org). Total Histone/dsDNA IgG ELISA
Antichromatin ELISAs were performed as described earlier (Mohan
et al., 1998), by using the conditions detailed in the figure legends.Quantitative RT-PCR
Splenic B cells were obtained by using Dynabeads mouse pan B
(B220) magnetic beads (Dynal), and total RNA was isolated by using Supplemental Data
Rneasy Mini kit (Qiagen). cDNA was synthesized with the TaqMan Supplemental Data including additional information regarding the
RT kit (Applied Biosystems). Quantitative real-time PCR was per- sequence and expression variations found in the SLAM/CD2 gene
formed on 10 ng cDNA on the GeneAmp 5700 with SYBR green family are available at http://www.immunity.com/cgi/content/full/
(Applied Biosystems); primer sequences are shown in Supplemental 21/6/769/DC1/.
Table S5. For each primer set, standard curves were generated by
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